Steven J. Altschuler

Sep 17, 2024 | nature.com | Xiaoxiao Sun |Steven J. Altschuler

AbstractDisease relapse driven by acquired drug resistance limits the effectiveness of most systemic anti-cancer agents. Targeting persistent cancer cells in residual disease before relapse has emerged as a potential strategy for enhancing the efficacy and the durability of current therapies. However, barriers remain to implementing persister-directed approaches in the clinic.

May 8, 2023 | timescall.com | Steven J. Altschuler

Before we answer that, a little math history is relevant. There is an investment/cost term called the “Rule of 72.” Simply stated, if you receive a 2% return on your investment and divide that into 72, you will double your money in 36 years. If you receive a 6% return you divide that into 72 and double your money in 12 years — and so on. The rule works the other way also.